RxSight, Inc. (RXST) stock
RXSTNasdaqOphthalmic GoodsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3076% below fair value
$4.83−0.47 (-8.87%)
Close on Nov 17, 2026Market cap $200.90MP/E –Yield –
RxSight market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
RxSight's market cap was $219.57M on Nov 11, 2026, against $469.15M a year earlier. Over the last 5 years it ranged from $199.47M to $2.24B, with a median of $428.07M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $219.57M | -48.7% |
| 2025 | Dec 31, 2025 | $428.07M | -69.1% |
| 2024 | Dec 31, 2024 | $1.38B | -4.3% |
| 2023 | Dec 29, 2023 | $1.45B | +311.6% |
| 2022 | Dec 30, 2022 | $351.20M | +14.3% |
| 2021 | Dec 31, 2021 | $307.40M | – |
See a number that looks wrong?